My Quote Request
6505-01-503-7204
20 Products
NDC00085-1177-02
EPTIFIBATIDE INJECT
NSN, MFG P/N
6505015037204
NSN
6505-01-503-7204
MFG
SCHERING CORP AN AFFIL OF SCHERING-PLOUGH CORP
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 920000
III PART NAME ASSIGNED BY CONTROLLING AGENCY: EPTIFIBATIDE INJECTION 100ML VIAL WITH 2MG/ML EPTIFIBATIDE SOLUTION
SPECIAL FEATURES: 2MG/ML, 100 ML VIAL; SOLUTION IS CLEAR, STERILE, COLORLESS, NON-PYROGENIC; FOR INTRAVENOUS (IV) USE; VIALS SHOULD BE STORED REFRIGERATED 2-8 DEG. C, OR AT ROOM TEMP. FOR UP TO 2 MONTHS ONLY; PROTECT FROM DIRECT LIGHT; DISCARD ANY UNUSED PORTION; TO HELP
~1: PATIENTS WITH SEVERE CARDIOVASCULAR DISEASES, HELPS PREVENT CLUMPING OF BLOOD CELLS
Related Searches:
02-1633
CALCIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505015037386
NSN
6505-01-503-7386
02-1633
CALCIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505015037386
NSN
6505-01-503-7386
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS CALCIUM CHLORIDE PER MILLILITER
ADMINISTRATION: INTRAVENOUS
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 401200
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CALCIUM CHLORIDE INJECTION USP 100ML 10S
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE
SPECIAL FEATURES: DISPOSABLE;LUER-LOCK NEEDLELESS SYRINGE; FOR TREATMENT OF HYPOCALCEMIA IN CONDITIONS REQUIRING A PROMPT INCREASE IN PLASMA CALCIUM; FOR TREATMENT OF MAGNESIUM INTOXICATION
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00409-1631-10
CALCIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505015037386
NSN
6505-01-503-7386
NDC00409-1631-10
CALCIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505015037386
NSN
6505-01-503-7386
MFG
HOSPIRA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS CALCIUM CHLORIDE PER MILLILITER
ADMINISTRATION: INTRAVENOUS
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 401200
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CALCIUM CHLORIDE INJECTION USP 100ML 10S
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE
SPECIAL FEATURES: DISPOSABLE;LUER-LOCK NEEDLELESS SYRINGE; FOR TREATMENT OF HYPOCALCEMIA IN CONDITIONS REQUIRING A PROMPT INCREASE IN PLASMA CALCIUM; FOR TREATMENT OF MAGNESIUM INTOXICATION
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
02-2823
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM SOLUTION,USP
NSN, MFG P/N
6505015037419
NSN
6505-01-503-7419
02-2823
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM SOLUTION,USP
NSN, MFG P/N
6505015037419
NSN
6505-01-503-7419
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 66.000 PERCENTAGE, W/V DIATRIZOATE MEGLUMINE ACTIVE INGREDIENT AND 10.000 PERCENTAGE, W/V DIATRIZOATE SODIUM ACTIVE INGREDIENT
ADMINISTRATION: ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 366800
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIATRIZOATE MEGLUINE 66%/DIATRIZOATE SODIUM 10% ORAL SOLUTION 120ML BT 12S
PRIMARY CONTAINER CONTENT QUANTITY: 120.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: USED FOR RADIOGRAPHIC EVALUATION OF THE ESOPHAGUS, STOMACH AND PROXIMAL SMALL INTESTINE, OR FOR DISORDERS OF THE SWALLOWING MECHANISM; 120 ML BOTTLES; PROTECT FROM LIGHT; STORE AT ROOM TEMPERATURE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
GASTROGRAFIN
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM SOLUTION,USP
NSN, MFG P/N
6505015037419
NSN
6505-01-503-7419
GASTROGRAFIN
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM SOLUTION,USP
NSN, MFG P/N
6505015037419
NSN
6505-01-503-7419
MFG
BRACCO DIAGNOSTICS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 66.000 PERCENTAGE, W/V DIATRIZOATE MEGLUMINE ACTIVE INGREDIENT AND 10.000 PERCENTAGE, W/V DIATRIZOATE SODIUM ACTIVE INGREDIENT
ADMINISTRATION: ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 366800
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIATRIZOATE MEGLUINE 66%/DIATRIZOATE SODIUM 10% ORAL SOLUTION 120ML BT 12S
PRIMARY CONTAINER CONTENT QUANTITY: 120.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: USED FOR RADIOGRAPHIC EVALUATION OF THE ESOPHAGUS, STOMACH AND PROXIMAL SMALL INTESTINE, OR FOR DISORDERS OF THE SWALLOWING MECHANISM; 120 ML BOTTLES; PROTECT FROM LIGHT; STORE AT ROOM TEMPERATURE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00270-0445-40
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM SOLUTION,USP
NSN, MFG P/N
6505015037419
NSN
6505-01-503-7419
NDC00270-0445-40
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM SOLUTION,USP
NSN, MFG P/N
6505015037419
NSN
6505-01-503-7419
MFG
BRACCO DIAGNOSTICS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 66.000 PERCENTAGE, W/V DIATRIZOATE MEGLUMINE ACTIVE INGREDIENT AND 10.000 PERCENTAGE, W/V DIATRIZOATE SODIUM ACTIVE INGREDIENT
ADMINISTRATION: ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 366800
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIATRIZOATE MEGLUINE 66%/DIATRIZOATE SODIUM 10% ORAL SOLUTION 120ML BT 12S
PRIMARY CONTAINER CONTENT QUANTITY: 120.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: USED FOR RADIOGRAPHIC EVALUATION OF THE ESOPHAGUS, STOMACH AND PROXIMAL SMALL INTESTINE, OR FOR DISORDERS OF THE SWALLOWING MECHANISM; 120 ML BOTTLES; PROTECT FROM LIGHT; STORE AT ROOM TEMPERATURE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
02-2779
PROTAMINE SULFATE INJECTION,USP
NSN, MFG P/N
6505015037425
NSN
6505-01-503-7425
02-2779
PROTAMINE SULFATE INJECTION,USP
NSN, MFG P/N
6505015037425
NSN
6505-01-503-7425
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS PROTAMINE SULFATE PER MILLILITER
ADMINISTRATION: INTRAVENOUS
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 201208
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PROTAMINE SULFATE INJECTION USP 50MG SINGLE DOSE VIAL 25/PG
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: PRESERVATIVE FREE; DOES NOT REQUIRE REFRIGERATION
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
6505NCM022068
PROTAMINE SULFATE INJECTION,USP
NSN, MFG P/N
6505015037425
NSN
6505-01-503-7425
6505NCM022068
PROTAMINE SULFATE INJECTION,USP
NSN, MFG P/N
6505015037425
NSN
6505-01-503-7425
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS PROTAMINE SULFATE PER MILLILITER
ADMINISTRATION: INTRAVENOUS
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 201208
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PROTAMINE SULFATE INJECTION USP 50MG SINGLE DOSE VIAL 25/PG
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: PRESERVATIVE FREE; DOES NOT REQUIRE REFRIGERATION
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC63323-0229-05
PROTAMINE SULFATE INJECTION,USP
NSN, MFG P/N
6505015037425
NSN
6505-01-503-7425
NDC63323-0229-05
PROTAMINE SULFATE INJECTION,USP
NSN, MFG P/N
6505015037425
NSN
6505-01-503-7425
MFG
VETERANS HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS PROTAMINE SULFATE PER MILLILITER
ADMINISTRATION: INTRAVENOUS
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 201208
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PROTAMINE SULFATE INJECTION USP 50MG SINGLE DOSE VIAL 25/PG
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: PRESERVATIVE FREE; DOES NOT REQUIRE REFRIGERATION
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
02-2806
MOXIFLOXACIN HYDROC
NSN, MFG P/N
6505015037443
NSN
6505-01-503-7443
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 082200
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MOXIFLOXACIN HYDROCHLORIDE SOLUTION IV 400MG READY TO USE 250ML LATEX FREE FLEXIBAG STER PRESERVATIVE FREE 0.8% SODIUM CHLORIDE AQUEOUS SOLUTION 12S
SPECIAL FEATURES: ADMINISTRATION: INTERVENOUS; 400 MG IN READY TO USE 250 ML LATEX-FREE FLEXIBAGS AS A STERILE, PRESERVATIVE FREE, 0.8% SODIUM CHLORIDE AQUEOUS SOLUTION; AN ANTIBIOTIC USED TO TREAT LUNG, SINUS, OR SKIN INFECTIONS CAUSED BY BACTERIA; STORE AT 25 DEGREES C
~1: (77 DEGREES F); DO NOT REFRIGERATE
Related Searches:
AVELOX
MOXIFLOXACIN HYDROC
NSN, MFG P/N
6505015037443
NSN
6505-01-503-7443
MFG
MERCK & CO. INC. DBA MERCK
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 082200
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MOXIFLOXACIN HYDROCHLORIDE SOLUTION IV 400MG READY TO USE 250ML LATEX FREE FLEXIBAG STER PRESERVATIVE FREE 0.8% SODIUM CHLORIDE AQUEOUS SOLUTION 12S
SPECIAL FEATURES: ADMINISTRATION: INTERVENOUS; 400 MG IN READY TO USE 250 ML LATEX-FREE FLEXIBAGS AS A STERILE, PRESERVATIVE FREE, 0.8% SODIUM CHLORIDE AQUEOUS SOLUTION; AN ANTIBIOTIC USED TO TREAT LUNG, SINUS, OR SKIN INFECTIONS CAUSED BY BACTERIA; STORE AT 25 DEGREES C
~1: (77 DEGREES F); DO NOT REFRIGERATE
Related Searches:
AVELOX IV
MOXIFLOXACIN HYDROC
NSN, MFG P/N
6505015037443
NSN
6505-01-503-7443
MFG
BAYER PHARMACEUTICALS CORPORATION
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 082200
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MOXIFLOXACIN HYDROCHLORIDE SOLUTION IV 400MG READY TO USE 250ML LATEX FREE FLEXIBAG STER PRESERVATIVE FREE 0.8% SODIUM CHLORIDE AQUEOUS SOLUTION 12S
SPECIAL FEATURES: ADMINISTRATION: INTERVENOUS; 400 MG IN READY TO USE 250 ML LATEX-FREE FLEXIBAGS AS A STERILE, PRESERVATIVE FREE, 0.8% SODIUM CHLORIDE AQUEOUS SOLUTION; AN ANTIBIOTIC USED TO TREAT LUNG, SINUS, OR SKIN INFECTIONS CAUSED BY BACTERIA; STORE AT 25 DEGREES C
~1: (77 DEGREES F); DO NOT REFRIGERATE
Related Searches:
NDC00026-8582-31
MOXIFLOXACIN HYDROC
NSN, MFG P/N
6505015037443
NSN
6505-01-503-7443
MFG
BAYER PHARMACEUTICALS CORPORATION
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 082200
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MOXIFLOXACIN HYDROCHLORIDE SOLUTION IV 400MG READY TO USE 250ML LATEX FREE FLEXIBAG STER PRESERVATIVE FREE 0.8% SODIUM CHLORIDE AQUEOUS SOLUTION 12S
SPECIAL FEATURES: ADMINISTRATION: INTERVENOUS; 400 MG IN READY TO USE 250 ML LATEX-FREE FLEXIBAGS AS A STERILE, PRESERVATIVE FREE, 0.8% SODIUM CHLORIDE AQUEOUS SOLUTION; AN ANTIBIOTIC USED TO TREAT LUNG, SINUS, OR SKIN INFECTIONS CAUSED BY BACTERIA; STORE AT 25 DEGREES C
~1: (77 DEGREES F); DO NOT REFRIGERATE
Related Searches:
NDC00085-1733-01
MOXIFLOXACIN HYDROC
NSN, MFG P/N
6505015037443
NSN
6505-01-503-7443
MFG
MERCK & CO. INC. DBA MERCK
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 082200
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MOXIFLOXACIN HYDROCHLORIDE SOLUTION IV 400MG READY TO USE 250ML LATEX FREE FLEXIBAG STER PRESERVATIVE FREE 0.8% SODIUM CHLORIDE AQUEOUS SOLUTION 12S
SPECIAL FEATURES: ADMINISTRATION: INTERVENOUS; 400 MG IN READY TO USE 250 ML LATEX-FREE FLEXIBAGS AS A STERILE, PRESERVATIVE FREE, 0.8% SODIUM CHLORIDE AQUEOUS SOLUTION; AN ANTIBIOTIC USED TO TREAT LUNG, SINUS, OR SKIN INFECTIONS CAUSED BY BACTERIA; STORE AT 25 DEGREES C
~1: (77 DEGREES F); DO NOT REFRIGERATE
Related Searches:
02-2905
ARTIFICIAL TEARS SOLUTION
NSN, MFG P/N
6505015038431
NSN
6505-01-503-8431
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ADMINISTRATION: OPHTHALMIC
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 523600
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ARTIFICIAL TEARS SOLUTION 15ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 3% HYDROXYPROPYL METHYLCELLULOSE SOLUTION; TO USE FOR DRYNESS IN THE EYES; PRESERVATIVE-FREE
Related Searches:
GENTEAL
ARTIFICIAL TEARS SOLUTION
NSN, MFG P/N
6505015038431
NSN
6505-01-503-8431
MFG
NOVARTIS OPHTHALMICS INC.
Description
ADMINISTRATION: OPHTHALMIC
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 523600
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ARTIFICIAL TEARS SOLUTION 15ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 3% HYDROXYPROPYL METHYLCELLULOSE SOLUTION; TO USE FOR DRYNESS IN THE EYES; PRESERVATIVE-FREE
Related Searches:
NDC58768-0788-15
ARTIFICIAL TEARS SOLUTION
NSN, MFG P/N
6505015038431
NSN
6505-01-503-8431
NDC58768-0788-15
ARTIFICIAL TEARS SOLUTION
NSN, MFG P/N
6505015038431
NSN
6505-01-503-8431
MFG
NOVARTIS OPHTHALMICS INC.
Description
ADMINISTRATION: OPHTHALMIC
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 523600
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ARTIFICIAL TEARS SOLUTION 15ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 3% HYDROXYPROPYL METHYLCELLULOSE SOLUTION; TO USE FOR DRYNESS IN THE EYES; PRESERVATIVE-FREE
Related Searches:
02-2901
FLUTICASONE PROPION
NSN, MFG P/N
6505015038443
NSN
6505-01-503-8443
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 680400
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FLUTICASONE PROPIONATE-SALMETEROL XINAFOATE INHALER DISPOSABLE 60 BLISTERS
SPECIAL FEATURES: ADVAIR DISKUS INHALATION DEVICE; CONTAINS 250MCG FLUTICASONE PROPIONATE AND SALMETEROL, 50MCG INHALATION POWDER; A DISPOSABLE, PURPLE-COLORED DEVICE CONTAINING 60 BLISTERS; PACKAGED WITHIN A PLASTIC-COATED, MOISTURE PROTECTIVE FOIL POUCH; PRODUCES
~1: IMPROVEMENT IN PULMONARY FUNCTION AND PREVENT SYMTOMS OF ASTHMA; STORE AT RM. TEMP. IN A DRY PLACE AWAY FROM DIRECT HEAT AND SUNLIGHT; DEVICE SHOULD BE DISCARDED 1 MONTH AFTER REMOVAL FROM THE PROTECTIVE FOIL POUCH
Related Searches:
ADVAIR DISKUS
FLUTICASONE PROPION
NSN, MFG P/N
6505015038443
NSN
6505-01-503-8443
MFG
GLAXO WELLCOME INC
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 680400
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FLUTICASONE PROPIONATE-SALMETEROL XINAFOATE INHALER DISPOSABLE 60 BLISTERS
SPECIAL FEATURES: ADVAIR DISKUS INHALATION DEVICE; CONTAINS 250MCG FLUTICASONE PROPIONATE AND SALMETEROL, 50MCG INHALATION POWDER; A DISPOSABLE, PURPLE-COLORED DEVICE CONTAINING 60 BLISTERS; PACKAGED WITHIN A PLASTIC-COATED, MOISTURE PROTECTIVE FOIL POUCH; PRODUCES
~1: IMPROVEMENT IN PULMONARY FUNCTION AND PREVENT SYMTOMS OF ASTHMA; STORE AT RM. TEMP. IN A DRY PLACE AWAY FROM DIRECT HEAT AND SUNLIGHT; DEVICE SHOULD BE DISCARDED 1 MONTH AFTER REMOVAL FROM THE PROTECTIVE FOIL POUCH
Related Searches:
NDC00173-0696-00
FLUTICASONE PROPION
NSN, MFG P/N
6505015038443
NSN
6505-01-503-8443
MFG
GLAXO WELLCOME INC
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 680400
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FLUTICASONE PROPIONATE-SALMETEROL XINAFOATE INHALER DISPOSABLE 60 BLISTERS
SPECIAL FEATURES: ADVAIR DISKUS INHALATION DEVICE; CONTAINS 250MCG FLUTICASONE PROPIONATE AND SALMETEROL, 50MCG INHALATION POWDER; A DISPOSABLE, PURPLE-COLORED DEVICE CONTAINING 60 BLISTERS; PACKAGED WITHIN A PLASTIC-COATED, MOISTURE PROTECTIVE FOIL POUCH; PRODUCES
~1: IMPROVEMENT IN PULMONARY FUNCTION AND PREVENT SYMTOMS OF ASTHMA; STORE AT RM. TEMP. IN A DRY PLACE AWAY FROM DIRECT HEAT AND SUNLIGHT; DEVICE SHOULD BE DISCARDED 1 MONTH AFTER REMOVAL FROM THE PROTECTIVE FOIL POUCH